The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms

E-ISSN： 1875-5992|9|6|703-715

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.6, 2009-07, pp. : 703-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives

By Ronellenfitsch Michael

Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. : 183-191

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1610-1618

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 6, 2010-07 ,pp. : 491-503

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

Current Cancer Therapy Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 65-77

Bentham Science Publishers

Access to resources Recommend Favorite

CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1381-1386

Spandidos Publications

Access to resources Recommend Favorite